Abstract
Meibomian gland loss in ocular GvHD was described as a mechanism contributing to dry eye and severe damage to the ocular surface. Infrared images of upper eyelid meibomian glands from 86 ocular GvHD patients, from 10 patients after allogeneic stem cell transplantation (aSCT) without ocular GvHD, from 32 patients prior to aSCT and from 30 healthy controls were analyzed retrospectively and evaluated using two grading schemes. The upper meibomian gland area (uMGA) was calculated and set in relation to the total tarsal area of the lid. Results demonstrate that meibomian gland loss is significantly increased in patients with ocular GvHD as well as in patients prior to aSCT in comparison with controls (P between 0.05 and <0.001). Patients after aSCT without ocular GvHD had no significant difference in uMGA in comparison with controls. This study suggests that meibomian gland loss in GvHD patients is likely to be a multifactorial process that also occurs prior to aSCT, possibly due to underlying diseases and/or secondary to chemotherapy or irradiation. In addition, the question has to be addressed whether meibomian gland loss could serve as a predictor for the development of ocular GvHD. Overall, infrared meibography should be included in routine examination of patients undergoing aSCT and during follow-up.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dietrich-Ntoukas T, Cursiefen C, Westekemper H, Eberwein P, Reinhard T, Bertz H et al. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German–Austrian–Swiss Consensus Conference on Clinical Practice in chronic GvHD. Cornea 2012; 31: 299–310.
Shikari H, Antin JH, Dana R . Ocular graft-versus-host disease: a review. Surv Ophthalmol 2013; 58: 233–251.
Espana EM, Shah S, Santhiago MR, Singh AD . Graft versus host disease: clinical evaluation, diagnosis and management. Graefe's Arch Clin Exp Ophthalmol 2013; 251: 1257–1266.
Eberwein P, Issleib S, Bohringer D, Mittelviefhaus H, Schwartzkopff J, Finke J et al. Conjunctival HLA-DR and CD8 expression detected by impression cytology in ocular graft versus host disease. Mol Vis 2013; 19: 1492–1501.
Ban Y, Ogawa Y, Ibrahim OM, Tatematsu Y, Kamoi M, Uchino M et al. Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. Mol Vis 2011; 17: 2533–2543.
Ibrahim OM, Matsumoto Y, Dogru M, Adan ES, Wakamatsu TH, Goto T et al. The efficacy, sensitivity, and specificity of in vivo laser confocal microscopy in the diagnosis of meibomian gland dysfunction. Ophthalmology 2010; 117: 665–672.
Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP et al. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant 2012; 47: 1470–1473.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.
Pult H, Riede-Pult B . Comparison of subjective grading and objective assessment in meibography. Contact Lens Anterior Eye 2013; 36: 22–27.
Arita R, Suehiro J, Haraguchi T, Shirakawa R, Tokoro H, Amano S . Objective image analysis of the meibomian gland area. Br J Ophthalmol 2013; 98: 746–755.
Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL . Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000; 118: 615–621.
Stodtmeister R, Kessler KF, Schlorer J . [Tear film break-up time with different stains]. Klin Monbl Augenheilkd 1983; 183: 110–114.
Bron AJ, Evans VE, Smith JA . Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003; 22: 640–650.
Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 1999; 83: 1125–1130.
Bray LC, Carey PJ, Proctor SJ, Evans RG, Hamilton PJ . Ocular complications of bone marrow transplantation. Br J Ophthalmol 1991; 75: 611–614.
Ferrara JL, Deeg HJ . Graft-versus-host disease. N Eng J Med 1991; 324: 667–674.
Acknowledgements
This study was supported by the Helmut und Ruth Lingen Stiftung, Cologne, Germany, by Oculus GmbH, Wetzlar, Germany, through loan of equipment and by Deutsche Forschungsgemeinschaft (DFG FOR 2240/STE 1928/4-1).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Engel, L., Wittig, S., Bock, F. et al. Meibography and meibomian gland measurements in ocular graft-versus-host disease. Bone Marrow Transplant 50, 961–967 (2015). https://doi.org/10.1038/bmt.2015.72
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2015.72
This article is cited by
-
Okuläre Graft-Versus-Host Erkrankung
Die Ophthalmologie (2023)
-
Meibomian Gland Dysfunction Clinical Practice Guidelines
Japanese Journal of Ophthalmology (2023)
-
Ocular Graft Versus Host Disease: Just a Severe Form of Dry Eye or Something More?
Current Ophthalmology Reports (2022)
-
The disposable bandage soft contact lenses therapy and anterior segment optical coherence tomography for management of ocular graft-versus-host disease
BMC Ophthalmology (2021)
-
Deep learning-based automatic meibomian gland segmentation and morphology assessment in infrared meibography
Scientific Reports (2021)